Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research

OBJECTIVES: Review of efficacy and safety of Janus kinase (JAK) inhibition in immune-mediated inflammatory diseases (IMIDs). METHODS: A systematic literature research (SLR) of all publications on JAK inhibitors (JAKi) treatment published until March 2019 using MEDLINE, EMBASE and the Cochrane Librar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerschbaumer, Andreas, Smolen, Josef S, Nash, Peter, Doerner, Thomas, Dougados, Maxime, Fleischmann, Roy, Geissler, Klaus, McInnes, Iain B, Takeuchi, Tsutomu, Trauner, Michael, Winthrop, Kevin, de Wit, Maarten, Boehncke, Wolf-Henning, Falzon, Louise, van der Heijde, Desirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Autoimmunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856126/
https://www.ncbi.nlm.nih.gov/pubmed/33188136
http://dx.doi.org/10.1136/rmdopen-2020-001374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856126/
https://www.ncbi.nlm.nih.gov/pubmed/33188136
http://dx.doi.org/10.1136/rmdopen-2020-001374

Ejemplares similares